Join Nostr
2026-08-19 18:56:23 UTC
in reply to

Nonilex on Nostr: In January, the companies announced results of a mid-stage trial of the treatment ...

In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

#Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

#PublicHealth #health #science #medicine #MedicalBreakthrough